Dortmund and Berlin, Germany, November 3, 2010
“From Sample to Assay – From R&D to IVD” was the title of a two-day workshop Scienion AG hosted in Berlin recently. Almost 100 participants from 12 countries benefited from an outstanding program covering topics from latest research applications, technology improvements to production issues.
Dortmund and Berlin, Germany, June 17, 2010
Scienion’s innovative dispensing technology is excellently suited for a variety of applications wherever contact-free precise handling of ultra low volume liquids is needed. For Prof. Peter H. Seeberger, Max Planck Institute of Colloids and Interfaces, the sciFLEYXARRAYER proved to be the best choice for the production of carbohydrate arrays.
Dortmund and Berlin, Germany, April 8, 2009
Scienion’s innovative dispensing technology is excellently suited for a variety of applications wherever contact-free precise handling of ultra low volume liquids is needed. Analytik Jena eBiochip GmbH recently started using this technology to coat electrical biochips. Die ultra low volume Dispensiertechnik der Scienion AG eignet sich hervorragend für eine Vielzahl von Anwendungen, bei denen es auf das berührungsfreie und präzise Handling kleinster Flüssigkeitsmengen ankommt. Die Analytik Jena eBiochip GmbH nutzt die Technologie seit kurzem, um neuartige elektrische Biochips damit zu bedrucken.
Dortmund, Germany, February 18, 2009
Scienion AG today announced the DIN EN ISO 9001:2008 certification for the development, manufacture and sales of dispensing systems and microarrays. Scienion is one of the first biotech companies that have been certified according to the latest revision of the world’s most widely used standard for quality management systems.
Dortmund and Berlin, Germany, January 20, 2009
SCIENION AG today announced the appointment of Dr. Guenter Bauer as Chief Business Officer to SCIENION’s management. The focus of his responsibilities will be sales and marketing. Bauer took up his new position on January 1, 2009. Die SCIENION AG gab heute bekannt, dass der Aufsichtsrat Dr. Günter Bauer als weiteres Vorstandsmitglied der Scienion AG bestellt hat. Der Schwerpunkt seines Verantwortungsbereichs liegt auf Vertrieb und Marketing (Chief Business Officer). Bauer trat seine neue Position zum 1. Januar 2009 an.
Dortmund, Germany and Spokane, WA, USA, January 12, 2009
Scienion AG and Matrical bioscience recently announced the launch of the sciSWIFTER™, a new dispensing device developed for high precision dispensing in 96, 384, and 1536 microplates. The sciSWIFTER will be jointly commercialized by Scienion AG and Matrical Bioscience, both leading suppliers in the life science market.
Dortmund and Berlin, Germany, November 19, 2008
Scienion AG launched two new models of its successful sciFLEXARRAYER dispensing systems, the perfect tools for automated ultra-low volume liquid handling of biological samples in the genomic and proteomic world. While the small sciFLEXARRAYER DW represents the ideal entry model, sciFLEXARRAYER SX is a scalable robotic dispensing platform that can be adjusted to the needed size of the working area when ordered. Substantial customer interest in both products at recent Medica in Düsseldorf.
Dortmund and Berlin, Germany, October 2, 2007
With its sciFLEXARRAYER S100 Scienion AG introduces a novel high throughput array and biosensor production instrument. The new S100 meets the high throughput production requirements of common bioarray formats like microtiter plates, slides, wafers and of biosensors. The system will be presented at Biotechnica, October 9-11, 2007 in Hanover
Dortmund and Berlin, Germany, April 10, 2007
With its sciFLEXARRAYER S3 Scienion AG has launched another model of its prize winning dispensing systems for ultra-low volume liquid handling. The piezo-driven system for non-contact dispensing was particularly developed as an economical entry for academic and R&D labs.
Berlin, Germany, July 18, 2006
Scienion AG has closed a financing round totaling more than 4.5 million Euro. The cash inflow enables the development of new technologies and thus the further expansion of the company. In order to develop these new technologies Scienion will establish a second development and production site in Dortmund and will move into new facilities in the BioMedizinZentrum Dortmund.